author-photo

Nabihah Tayob

Harvard University

29

Papers

63

Citations

Citation Trend

Filter By

Papers (23) Sort By

Journal Conference Others

Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial).

2021 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (1)
Saci-IO TNBC: Randomized phase II trial of sacituzumab govitecan (SG) +/- pembrolizumab in PD-L1– metastatic triple-negative breast cancer (mTNBC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Twenty-year risks of breast cancer-specific mortality for stage III breast cancer in the surveillance, epidemiology, and end results registry.

2021 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (0)
A phase II study of efficacy, toxicity, and the potential impact of genomic alterations on response to eribulin mesylate in combination with trastuzumab and pertuzumab in women with human epidermal growth factor receptor 2 (HER2)+ metastatic breast cancer.

2021 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (0)
Saci-IO HR+: Randomized phase II trial of sacituzumab govitecan (SG) +/- pembrolizumab in PD-L1+ hormone receptor-positive (HR+) / HER2- metastatic breast cancer (MBC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Feasibility of an Online Patient Community to Support Older Women With Newly Diagnosed Breast Cancer

2021 Clinical Breast Cancer
Show All
- Source
- Cite
- Save
Citations (0)
A phase 2, two-stage study of avelumab and axitinib in patients with mismatch repair proficient (MMR-P) recurrent or persistent endometrial cancer (EC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Prospective Study Testing a Simplified Paclitaxel Premedication Regimen in Patients with Early Breast Cancer.

2021 Oncologist
Show All
- Source
- Cite
- Save
Citations (0)
Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (12)
Doylestown Plus and GALAD Demonstrate High Sensitivity for HCC Detection in Patients with Cirrhosis.

2021 Clinical Gastroenterology and Hepatology
Show All
- Source
- Cite
- Save
Citations (3)